Wonder Drug, page-4

@vrs37 You are strawmanning. No one is "touting this as a drug that’ll prevent long Covid". @RBx clearly states that larger clinical trials are needed. Literally no one is denying that more trials are needed.

"what's your evidence?" You shriek? And, once again you have failed to read past the headline and are embarrassing yourself. Here's a quote:

Associate Professor Michael Gantier, Head of the Nucleic Acids and Innate Immunity Laboratory at
Hudson Institute said: “TBK1 is a point of convergence of many inflammatory pathways, and a target
under significant investigation by several big pharmaceutical companies. Our latest findings, which are
being prepared for publication, demonstrate that idronoxil may have applications in a range of diseases
where TBK1 facilitates aberrant inflammation. Critically, TBK1 also directly controls production of
interferon-beta, a cytokine associated with long-COVID symptoms. This suggests that idronoxil may not
only be useful to prevent progression of COVID-19 patients from mild to severe disease, but also may
decrease the risk of long-lasting post-infectious symptoms, seen in up to half of COVID-19 patients.”

And you are likening Gantier's research to "the sort of whacky stuff you see on Facebook"? Pathetic.